Florian Hager
Corporate Officer/Principal presso BLACKSTONE INC.
Profilo
Florian Hager is currently a Managing Director in the Credit Division at Blackstone, Inc. He is also a Director at Axonix Ltd.
and a Principal at GSO Capital Partners (UK) Ltd.
Previously, he served as a Non-Executive Director at Advanz Pharma Corp.
Ltd.
Mr. Hager completed his undergraduate studies at Vienna University of Economics & Business and holds an MBA from The University of Chicago Booth School of Business.
Posizioni attive di Florian Hager
| Società | Posizione | Inizio |
|---|---|---|
| BLACKSTONE INC. | Corporate Officer/Principal | 01/10/2012 |
| GSO Capital Partners (UK) Ltd. | Private Equity Investor | - |
Axonix Ltd.
 Axonix Ltd. Advertising/Marketing ServicesCommercial Services Axonix Ltd. operates as mobile advertising company. It offers solutions for mobile operators and data providers, advertisers and demand partners, and publishers. The company was founded in 2014 and is headquartered in London, the United Kingdom. | Director/Board Member | 31/10/2019 |
Precedenti posizioni note di Florian Hager
| Società | Posizione | Fine |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Director/Board Member | - |
Formazione di Florian Hager
| Vienna University of Economics & Business | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BLACKSTONE INC. | Finance |
| Aziende private | 3 |
|---|---|
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
Axonix Ltd.
Axonix Ltd. Advertising/Marketing ServicesCommercial Services Axonix Ltd. operates as mobile advertising company. It offers solutions for mobile operators and data providers, advertisers and demand partners, and publishers. The company was founded in 2014 and is headquartered in London, the United Kingdom. | Commercial Services |
| GSO Capital Partners (UK) Ltd. | Finance |
- Borsa valori
- Insiders
- Florian Hager
